Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-05-240899
Filing Date
2005-12-13
Accepted
2005-12-12 17:32:25
Documents
6
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 1 d10ka.htm 10-K/A 616639
2 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS dex231.htm EX-23.1 2821
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9236
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9293
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4247
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4237
  Complete submission text file 0001193125-05-240899.txt   647869
Mailing Address 6330 QUADRANGLE DR SUITE 240 CHAPEL HILL NC 27514
Business Address 6330 QUADRANGLE DR SUITE 240 CHAPEL HILL NC 27514 9194900012
POZEN INC /NC (Filer) CIK: 0001059790 (see all company filings)

EIN.: 621657552 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-31719 | Film No.: 051259248
SIC: 2834 Pharmaceutical Preparations